Biogen Inc.BIIBNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank36
3Y CAGR-4.3%
5Y CAGR-9.5%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
-4.3%/yr
vs -15.7%/yr prior
5Y CAGR
-9.5%/yr
Recent acceleration
Acceleration
+11.4pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.10B | +3.5% |
| 2024 | $3.00B | +26.0% |
| 2023 | $2.38B | -32.8% |
| 2022 | $3.54B | -9.9% |
| 2021 | $3.92B | -23.2% |
| 2020 | $5.11B | -34.0% |
| 2019 | $7.74B | +10.3% |
| 2018 | $7.01B | +6.2% |
| 2017 | $6.61B | +4.1% |
| 2016 | $6.35B | - |